-+ 0.00%
-+ 0.00%
-+ 0.00%

Ubhar Capital Oman Upgrades Jamjoom Pharmaceuticals to Buy, Trims PT

MT Newswires·07/27/2026 08:28:25
Listen to the news
08:28 AM EDT, 07/27/2026 (MT Newswires) -- Ubhar Capital Oman on Sunday upgraded pharmaceutical company Jamjoom Pharmaceuticals Factory (SASE:4015) to buy from hold and reduced its price target to 155.70 Saudi riyals from 160 riyals. (MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www.mtnewswires.com/contact-us)